Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies
Summary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel…